Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver

Pharmacogenetics

Volumn 4, Issue 1, 1994, Pages 11-20

  Schuetz, John D ^a   Guzelian, Philip S ^a   Beach, Deborah L ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P 450 CYP2E1; CYTOCHROME P 450 ENZYME SYSTEM; CYTOCHROME P450; CYTOCHROME P450 2E1; MESSENGER RNA; MIXED FUNCTION OXIDASE; PRIMER DNA; CEFAZOLIN; COMPLEMENTARY DNA; CONJUGATED ESTROGEN; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; DOPAMINE; ERYTHROMYCIN; FLURAZEPAM; FUROSEMIDE; GENTAMICIN; GLYCOPYRRONIUM BROMIDE; HYDROXYZINE; ISONIAZID; ISPAGULA; MIDAZOLAM; MORPHINE; NEOMYCIN; OLIGONUCLEOTIDE; PARACETAMOL; PETHIDINE; PHENYTOIN; SULFAMETHOXAZOLE; THYROXINE; TRIAZOLAM; VASOPRESSIN;

ADULT; ARTICLE; COMPARATIVE STUDY; EMBRYOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; HUMAN; LIVER; MOLECULAR GENETICS; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; CONTROLLED STUDY; FEMALE; FETUS; GENE EXPRESSION; HUMAN TISSUE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL;

ADULT; BASE SEQUENCE; COMPARATIVE STUDY; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMAN; LIVER; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028175687     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199402000-00002     Document Type: Article

References (43)

1. Albretsen C, Haukanes BI, Aasland R, Kleppe K. Optimal conditions for hybridization with oligonucleotides: A study with myc-oncogene DNA probes. Anal Biochem 1988: 170. 193-202
2. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, Gonzalez FJ. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J Biol Chinn 1989: 204. 10388-10395
3. Aoyama T, Gelboin HV, Gonzalez FJ. Mutagenic activation of 2-amino-3-methylimidazo[4, 5-f]quinoline by complementary DNA-expresscd human liver P-450. Cancer Res 1990a: 50. 2060-2063
4. Aoyama T, Yamano S, Guzelian PS, Gelboin IIV, Gonzalez FJ. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B,. Proc Natl Acad Sci USA 1990b: 87, 4790-4793
5. Ahsan CH. Renwick AG, Macklin B, Challenor DG, Waller DG, George CF. Ethnic differences in the pharmacokinetics of oral nifedipine. Br J Clin Pharmacol 1991: 31, 399-403
6. Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci USA 1986: 83. 8064-8068
7. Bell GI, Karam JH, Rutter WJ. Polymorphic DNA region adjacent to the 5’ end of the human insulin gene. Proc Natl Acad Sci USA 1981: 78, 5759-5763
8. Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Client 1989: 264, 910-919
9. Breimer DD, Schellens JHM, Soons PA. Nifedipine: Variability in its kinetics and metabolism in man. Pharmacol Ther 1989: 44. 445-454
10. Devereux J, Haeberli P, Smithes O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1984: 12, 387-395
11. Gonzalez FJ, Song BJ, Hardwick JP. Pregnenolone 16 alpha-car-bonitrile-inducible P-450 gene family: Gene conversion and differential regulation. Mol Cell Biol 1986: 6, 2969-2976
12. Gonzalez FJ, Schmid BJ, Umeno M, McBride OW, Hardwicke JP, Meyer UA, Gelboin HV. Idle JR. Human P450PCN1: sequence, chromosome localization, and evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 1988: 7. 79-86
13. Gonzalez FJ, Aoyama T, Gelboin HV. Activation of promutagens by human cDNA-expressed cytochrome P450s. Prog Clin Biol Res 1990: 340B. 77-86
14. Graves PE, Kaminsky LS, Halpert J. Evidence for functional and structural multiplicity of pregnenolone-16a-carbonitrile- inducible cytochrome P-450 isozymes in rat liver microsomes. Biochemistry 1987: 26, 3887-3894
15. Guengerich FP, Martin MV, Beaune PH, Kremers P. Wolff T, Waxman DJ. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism, J Biol Client 1986: 261, 5051-5060
16. Jones KW, Whitlock JP. Functional analysis of the transcriptional promoter for the CYP1A1 gene. Mol Cell Biol 1990: 10, 5098-5104
17. Kitada M, Kamatski T, Itahashi K. Rikihisa T, Kanakubo T. P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16a-hydroxylase of dehydroepiandrosterone 2 sulfate. J Biol Chem 1987: 262, 13534-13537
18. Kitada M, Tsukidate K, Takeuchi J, Taneda M, Komori M, Ohi H, Itahashi K, Kamataki T. Immunochemical studies for the presence of P-450 HFLa, a form of cytochrome P-450 in human fetal livers in human hepatocellular carcinoma cells. J Pharmacohio-Dyn 1989: 12, 341-344
19. Komori M. Nisliio K. Ohi II. Kitada M. Kamataki T. Molecular cloning and sequence analysis of eDNA containing the entire coding region for human fetal liver cytochrome P-450. I Biochem (Tokyo) 1989: 105. 161-163
20. Komori M, Nishio K, Kitada M, Shiramatsu K, Muroya K, Soma M, Hagashima K, Kamataki T. Fetus-specific expression of a form of cytochrome P-4 50 in human livers. Biochemistry 1990: 29. 4430-4433
21. Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988: 43. 630-635
22. Leroux JP, Crested T, Marie S. Ontogeny and regulation of drug metabolism in humans Phase I: Monooxygenases. Dev Pharmacol Ther 1990: 13. 63-69
23. Liu J-K, Di Persio Mand, Zaret KS. Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. Mol Cell Biol 1991: 11, 773-784
24. Messing J. New Ml3 vectors for cloning. Methods F. nzymol 1983: 101, 20-78
25. Molowa DT, Schuetz EG. VVrighton SA. Watkins PB. Kremers P, Mendez-Picon G. Parker GA. Guzelian PS. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci USA 1986: 83. 5311-5315
26. Murray GI, Barnes TS, Sewell HF, Ewen SWB, Melvin WT, Shaw PM. Fowler J, Burke MD. Cytochrome P-450 localization in normal human adult and foetal liver by immuno- cytochemistry using a monoclonal antibody against human cytochrome P-450. Histochem J 1987: 19, 537-545
27. Murray GI, Barnes TS, Sewell HF. Ewen SWB. Melvin WT, Burke MD. The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmacol 1988: 25. 465-475
28. Nakahori Y, Mitani K, Yamada M, Nakagome Y. A human Y-chromosome specific repeated DNA family (DYZ1) consists of a tandem array of pentanucleotides. Nucleic Acids Res 1986: 14, 7569-7580
29. Nebert DW, Nelson DR, Coon MJ, Estabrook RW, Feyereisen R, Fujii-Kuriyama Y, Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson EF, Loper JC, Sato R. Waterman MR, Waxman DJ. The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 1991: 10. 1-14
30. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci USA 1977: 74, 5463-5467
31. Sano K. Fujioka Y, Hagashima K, Hashizume T, Komori M. Kitada M, Kamataki T, Miyazaki T. Distributional variation of P-450 immunoreactive hepatocytes in human fixer disorders. Human Pathol 1989: 20, 1015-1020
32. Schuetz JD, Molowa DT, Guzelian PS. Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch Biochem Biophys 1989: 274, 355-365
33. Schuetz JD, Kauma S, Guzelian PS. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J Clin Invest 1993: 92, 1018-1024
34. Shimada T. Guengerich FP. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci USA 1989a: 86, 462-465
35. Shimada T, Iwasaki M. Martin MV, Guengerich FP. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in salmonella typhimurium TA 1 535/pSK1002. Cancer Res 1989b: 49, 3218-3228
36. Simmons DL. Kasper CB. Quantitation of mRNAs specific for the mixed-function oxidase system in rat liver and extrahepatic tissues during development. Arch Biochem Biophys 1989: 271, 10-20
37. Watkins PB, VVrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, Guzelian PS. Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci USA 1985: 82. 6310-6314
38. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. The erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. J Clin Invest I 1989: 83, 688-697
39. Watkins PB, Hamilton TA. Annesley TM, Ellis CN. Kolars JC, Voorhees JJ. The erythromycin breath test as a predictor of cyclosporine blood levels. Clin Pharmacol Ther 1990: 48, 120-129
40. Waxman DJ, Morrissey JJ, Leblanc GA, Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: Pituitary control of hepatic NADPH cytochrome P-450 reductase. Mol Pharmacol 1989: 35. 519-525
41. Waxman DJ, Ram PA, Notani G, Leblanc GA, Alberta JA, Morrissey JJ, Sundseth SS. Pituitary regulation of the malespecific steroid 6β-hydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppressive influence of growth hormone and thyroxine acting at a pretranslational level. Mol Endocrinol 1990: 4. 447-454
42. Wrighton SA. Ring BJ, Watkins PB, Vandenbranden M. Identi-. fication of a polymorphically expressed member of the human cytochrome P-450III family. Mol Pharmacol 1989: 36, 97-105
43. Wrighton SA, Brian WR, Sari M-A, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, Vandenbranden M. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 1990: 38, 207-213